Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
The money raised through the Offer for Sale goes to existing investors, not the company.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
No peer comparisons added yet.
Vijaya Diagnostic Centre Limited, established in 1981, operates one of the larger integrated diagnostic chains in Southern India, providing pathology and radiology testing along with cardiology, neurology and gastroenterology related diagnostic services. The company runs a hub-and-spoke network of around 80 diagnostic centers and 11 reference laboratories spread across roughly 13 cities and towns in Telangana, Andhra Pradesh, the National Capital Region and Kolkata. The company's laboratories carry NABL accreditation, with a number of centers also NABH accredited, reflecting the quality standards it applies across its testing operations. It employs a large team of radiologists, pathologists and other healthcare professionals, and in the year of its public issue it processed several million pathology and radiology tests for a customer base running into the millions, indicative of the scale it had reached as a regional diagnostics operator. The company's initial public offer in September 2021 was structured entirely as an offer for sale by its founder-promoter and existing private-equity investors, meaning the listing itself did not raise fresh capital for the business but instead gave existing shareholders a partial exit and brought the company onto the public markets. Its financial performance in the years leading up to listing showed steady growth in both revenue and profit, consistent with the broader expansion of organised diagnostic chains in India over that period.
The company raised approximately Rs 566 crore from 41 anchor investors, including 9 mutual funds across 18 schemes, at Rs 531 per equity share on August 31, 2021, ahead of the public issue opening.
Source: RHP • Analysis provided for informational purposes
Last Updated: 21 July 2026, 5:30 AM
Established regional brand
The company has built a well recognized diagnostics brand across Southern India over four decades, supported by an award-winning service reputation and a large, experienced base of healthcare professionals.
Significant geographic footprint
Its network of diagnostic centers and reference laboratories spans multiple cities across several states, giving it broader reach than many regional peers.
No proceeds to the company
Since the entire issue was an offer for sale by the promoter and existing investors, the listing did not raise any fresh capital for the company itself.
Vijaya Diagnostic Centre Limited
No. 6-3-883/F, FPA Building, Near Topaz Building, Punjagutta, Hyderabad, Telangana 500082, India
View on Maps →No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.